JP Morgan Maintains Overweight on Braze, Lowers Price Target to $34

Benzinga · 1d ago
JP Morgan analyst Alexei Gogolev maintains Braze (NASDAQ:BRZE) with a Overweight and lowers the price target from $35 to $34.